Daniel Berg

Daniel Berg is a seasoned professional in the pharmaceutical and biotechnology sectors, currently serving as Regional Business Development Manager at Scendea since September 2025. Prior experience includes a role as Business Development Director at Fortrea, focusing on Clinical Pharmacology Services, and a similar position at Labcorp Drug Development. Daniel held the position of Clinical Program Director at Kazia Therapeutics Limited, overseeing innovative cancer treatment developments. Other significant roles include Head of Project Management at Novogen, Principal Consultant at Daniel Berg Consultancy, and various management positions at sanofi-aventis and Pharmaxis Ltd. Daniel's extensive background in project and operations management, alongside a BSc Hons in Medicinal Chemistry from the University of Sussex, underlines a strong foundation in clinical research and development.